Determination of Cerebrospinal Fluid Proteome Variations by Isobaric Labeling Coupled with Strong Cation-Exchange Chromatography and Tandem Mass Spectrometry-Reference-Cited by-同舟云学术

Determination of Cerebrospinal Fluid Proteome Variations by Isobaric Labeling Coupled with Strong Cation-Exchange Chromatography and Tandem Mass Spectrometry

Published:2019 Issue: Volume: Page:155-168
ISSN:1064-3745
Container-title:Methods in Molecular Biology
language:
Short-container-title:

Author:

Lachén-Montes Mercedes,González-Morales Andrea,Fernández-Irigoyen Joaquín,Santamaría Enrique

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4939-9706-0_10

Reference41 articles.

1. Heemels MT (2016) Neurodegenerative diseases. Nature 539:179

2. Dos Santos Picanco LC, Ozela PF et al (2018) Alzheimer’s disease: a review from the pathophysiology to diagnosis, new perspectives for pharmacological treatment. Curr Med Chem 25:3141–3159

3. Lista S, Zetterberg H et al (2017) Evolving relevance of neuroproteomics in Alzheimer’s disease. Methods Mol Biol 1598:101–115

4. Shahim P, Mansson JE et al (2013) Cerebrospinal fluid biomarkers in neurological diseases in children. Eur J Paediatr Neurol 17:7–13

5. Blennow K, Hampel H et al (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6:131–144

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroproteomics: How a Multitude of Proteins Reflect Brain Functions;Biology Bulletin Reviews;2021-03

2. The separation sciences, the front end to proteomics: An historical perspective;Biomedical Chromatography;2020-10-30

3. Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy;Acta Neuropathologica;2020-01-06